Preparation of treatments
ARQ 092 was kindly provided by ArQule Inc (Woburn, MA, USA).
For in vitro studies, Sorafenib tosylate (Bay 43-9006, Sigma-Aldrich, Germany), and ARQ 092 were dissolved in pure dimethylsulfoxyde (DMSO, SigmaAldrich). ARQ 092 was stored at -20°C temperature and protected from light. Combination was prepared by mixing of single drugs just before the start of in vitro experiments.
For in vivo study, 200 mg Sorafenib tosylate tablets (Nexavar ® , Bayer HealthCare, Germany) were used and prepared as previously described (1) . The sugar coating was first dissolved in DMSO and Sorafenib was mixed with 1 mL of poly-oxyl castor oil (Cremophor ® EL, Sigma-Aldrich) and 1 mL of 95% ethanol per tablet to emulsify and solubilize it. To finish, the emulsion was diluted in purified water to obtain a 10 mg/mL solution of Sorafenib suitable for oral gavage.
ARQ 092 was dissolved in a 0.01M phosphoric acid solution to obtain a 7.5 mg/mL ARQ 092 solution suitable for oral gavage with a final pH of 2.25 ± 0.15.
Fresh solutions of each drug were prepared every week and stored at room temperature, protected from light. Combination was prepared by mixing the same volume of single drugs just before oral gavage.
Cell viability assay
Cell viability was determined by MTT (Sigma-Aldrich) (3-(4, 5-Dimethylthiazol-2-yl)-2, ) during 48h. CI values were calculated with an implementation of the Median-Effect approach of Chouand Talalay using CompuSyn software as described previously (2) . CI=1 indicates an additive effect, CI>1 indicates antagonism, CI<1 indicates a synergistic effect and CI <0.1 indicates very strong synergistic effect (3).
As a negative control, cells were incubated in the same medium with 1 % DMSO without drug. Each sample was analyzed on three replicates and all experiments were repeated three times.
Apoptosis assay
Apoptosis assay was performed on 4 cell lines treated with IC20 and IC50 concentrations of Sorafenib, ARQ092 or with Combination IC50/200 and Combination IC50/10 during 48h. Annexin V (BD biosciences, USA; early-stage apoptosis marker) conjugated to FITC and 7-amino-actinomycin D (7-AAD, BD biosciences) positive cells were measured by flow cytometry (BD Accuri C6, BD biosciences, USA).
Cell migration
Cell migration was assessed on 4 cell lines by wound-healing assay and cells were then treated with IC20 and IC50 concentrations of Sorafenib or ARQ 092 or with Combination IC50/200 and Combination IC50/10. Images were captured every hour by time-lapse microscopy at 37°C, 5% CO 2 with Zeiss AxioVert 100M connected to a MicroMAX B/W (6.7x6.7 μm, -15°, ~ 3 im/s) camera using MetaMorph ® software (MetaMorph Inc., USA). The width of the wound was quantified at 24 h by software ImageJ. Data are presented as relative percentage of closed-wound. The experiments were performed in duplicates and repeated at least three times. Cell velocity was determined via tracking cells by time-lapse microscopy. Cells were then treated with IC20 and IC50 concentrations of ARQ 092 or sorafenib and images of cells were captured every hour by timelapse microscopy with Zeiss AxioVert 100M connected to a MicroMAX B/W camera. To estimate the velocity, 4 different areas per sample were captured and 5 cells per area were tracked using the Manual Tracking plugin for Image J.
MRI studies
Imaging study was performed with a 4.7 Tesla MR Imaging system (BioSpec 47/40 USR, Bruker Corporation, Germany) and Transmit/Receive Volume Array Coil for rat body 8x2 (Bruker Corporation, Germany) in the Grenoble MRI facility IRMaGE. Rats were fitted in ventral decubitus position and anesthetized with isoflurane inhalation (Forane ® , Abbott, USA). Breathing was continuously monitored to maintain a respiratory rate between 35 and 45 breaths per minute and body temperature was maintained around 37°C.
We used Turbo rapid acquisition with relaxation enhancement T2-weighted (Turbo-RARE T2) sequence (repetition time (TR): 1532.9 msec, echo time (TE): 27.4 msec, flip angle (FA): 180°) with a field of view (FOV) of 55 x 55 mm, 20 slices, a thickness and a slice separation of 2 mm, and were realized with a respiratory triggered acquisition to reduce artefacts. MRI parameters adjustment and image acquisition were realized by using Paravision 5.1 software.
A morphological analysis was realized based on the TurboRARE T2 sequences and according to the Response Evaluation Criteria in Solid Tumors (RECIST) criteria. Ten liver tumors were selected and measured on MRI1, 2 and 3. Estimated tumor size corresponded to the sum of the largest diameter of these 10 lesions. For each rat, MRI1 was considered as the baseline (i.e.: 0%) and tumor progression corresponded to the comparison between MRI2 or 3 and the baseline, (i.e: "(tumor size MRI2/3 -tumor size MRI1 )/tumor size MRI1 ).
Histopathological, immunohistochemical and immunofluorescence analyses
Liver tissues were fixed in 10% formalin solution, neutral buffered (Sigma-Aldrich). Paraffin-embedded, four-micrometer sections were then stained with Hematoxylin/Eosin.
To detect proliferating cells, paraffin-embedded sections were incubated overnight at 4°C with the primary anti-Ki67 antibody (Rabbit, clone SP6, Thermofisher scientific, USA), followed by incubation with the peroxidase-conjugated bovine anti-rabbit IgG (Jackson ImmunoResearch, USA). DAB was used as the chromogen for Ki67 immunodetection. For Ki67 + cells, data are presented as positive cell nuclei per area (highpower fields; 20x magnification).
Apoptotic cells were analysed by ApoBrdU-IHC DNA Fragmentation Assay Kit (Biovision, USA) and methyl green solution was used for counter staining the cells. Data are presented as apoptotic cells per area (highpower fields; 20x magnification).
To detect vascularisation, paraffin-embedded sections were blocked by 10% donkey serum and then incubated overnight at 4°C with anti-rat CD34 antibody (Goat, AF4117, R&D Systems; Minneapolis, USA), followed by incubation with Alexa 647-conjugated donkey anti-goat IgG (Life Technologies, Carlsbad, CA, USA). Images were captured using ApoTome microscope (Carl Zeiss, Germany) equipped with a camera AxioCam MRm and collected by AxioVision software. Positive area was quantified using ImageJ software (NIH, USA) on 15 randomly selected fields/section (10x magnification).
Collagen was detected on paraffin-embedded sections with picro-sirius red stain solution (SigmaAldrich) and staining was subsequently quantified by MetaMorph ® software in 10 randomly selected fields/ section (10x magnification).
Oil Red O staining was performed on 7μm cryosections, prepared from formalin pre-fixed liver samples. Sections were stained with freshly prepared Oil Red O in isopropanol. Oil Red O staining provides chromogenic as well as fluorescent signals, therefore we used red channel to detect staining. Images were captured using ApoTome microscope (Carl Zeiss, Germany) equipped with a camera AxioCam MRm, collected by AxioVision software and quantified using ImageJ software (NIH, USA). For Oil Red O + liver area, data are presented as Oil Red O positive area in percent of total tissue area. Six random areas per each liver section were analysed.
Real-time polymerase chain reaction (qPCR)
Total RNA was extracted from frozen rat liver tissue samples. RNA purification was performed with RNeasy Mini Kit ® (Qiagen, USA). Reverse transcription was realized with Transcriptor First Strand cDNA Synthesis Kit ® (Life science, Roche), and amplification reactions were performed in a total volume of 20μL by using a Thermocycler sequence detector (BioRad CFX96, USA) with qPCR kit Mesa Green qPCR MasterMix Plus for SYBR Assay ® (Eurogentec, Belgium). GADPH was used as housekeeping gene. Primers were designed with Primer 3 software (version 4.0.0) and verified on BLAST. Oligonucleotide sequences were synthetized by Eurofins Genomics ® in 0.01μmol scale, with a Salt Free level of purification. Every analysis was done in duplicates.
Immunoblot analysis
Liver homogenates were prepared in RIPA buffer (50 mM Tris; 1% NP40; 0.5% deoxycholic acid sodium salt; 150 mM NaCl; 1 mM EGTA) containing Protease and Phosphatase Inhibitors, and proteins were quantified with NanoDrop ® (Thermofisher scientific). Proteins were then denatured in Laemmli Sample Buffer (BioRad) containing 5% β-mercaptoethanol and separated by gel electrophoresis (Mini Protean Gels ® , Bio-Rad) and transferred to polyvinylidene difluoride (PVDF; BioRad) membranes using a wet blot method. Membranes were blocked in TBS-Tween solution with 5% BSA for 1 h at 4°C. Primary antibodies against p-Akt (Ser473) , Akt (pan) , pERK (Thr202/Tyr204)
, ERK (p44/42 MAPK) , β-actin (all Cell Signaling Technology, USA) were incubated at 4°C overnight under shaking conditions. Incubation with the secondary antibody (HRP-anti rabbit IgG, 1:2000; Cell Signaling) was performed under shaking conditions for 1 h. Detection was achieved with Clarity™ Western ECL Blotting Substrate (Bio-Rad) using a ChemiDoc™ MP Imaging System (Bio-Rad). Densitometric quantification of the bands was performed using the Image Lab™ Software (Bio-Rad).
Flow cytometric analysis
Cells were recovered from liver tissue by mechanical disruption and whole blood samples were used in case of blood analyses. Cells were immunostained for flow cytometric analysis without any stimulation.
Following anti-rat antibodies were used: CD45 (Clone:OX-1, APC/Cy7, BioLegend), CD3 (Clone:1F4, BV605, BD Horizont), Granulocytes (Clone:RP-1, PE, BD Pharmingen), CD8 (Clone:G28, APC, BioLegend), CD4 (Clone:W3/25, PE/Cy7, BioLegend), CD161 (Clone:3.2.3, FITC, BioLegend), CD90 (Clone:OX-7, BV711, BioLegend), CD47 (PE, OX-101, BioLegend). Nonviable cells were stained by Zombie UV™ Fixable Viability Kit (BioLegend) and excluded from the analysis. Isotype-matched antibodies were used as control. Data were acquired on BD-LSRII flow cytometer (BD Biosciences, Le Pont-De-Claix, France), collected with BD FACSDiva 6.3.1 software and analyzed using FCS Express 6 PLUS software.
